Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced ...

Mark Esser, PhD, was appointed the inaugural chief scientific officer and head of the upcoming Paul and Diane Manning Institute of Biotechnology at Charlottesville-based University of Virginia. In his ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses results from new data on the role of T cell dysfunction in post-acute infection syndromes.

The Minister of Information and National Orientation, Mohammed Idris, has sounded the alarm over the growing threat of ...

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces the promotion of Donovan Quill to chief strategy officer, Life ...

The number of children living with autism in the U.S. is growing. About 1 in 31 children aged eight years old in 2022 had ...

Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological ...

An eye check up is more than just about finding vision issues. A thorough eye or retinal scan can, in fact, reveal early signs of hypertension, diabetes, cardiovascular issues and Alzheimer's ...

Deputy Prime Minister Datuk Seri Dr Ahmad Zahid Hamidi has extended a warm and heartfelt welcome to Chinese President Xi ...

Sidra Medicine, a member of Qatar Foundation, will host the second edition of its international conference, Artificial Intelligence ...

“The Hospitality Summit has been a key initiative allowing greater alignment across the hospitality and tourism sectors. The ...

Colossal Biosciences, an American biotechnology company, announced the "de-extinction" of the dire wolf, a prehistoric wolf ...